Legal Representation
Attorney
Timothy H. Hiebert
USPTO Deadlines
Application History
50 events| Date | Code | Type | Description |
|---|---|---|---|
| Jul 9, 2018 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
| Jul 9, 2018 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| Nov 7, 2017 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Nov 6, 2017 | EX5G | S | SOU EXTENSION 5 GRANTED |
| Oct 11, 2017 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Oct 11, 2017 | EXT5 | S | SOU EXTENSION 5 FILED |
| May 27, 2017 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| May 25, 2017 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| May 25, 2017 | EXT4 | S | SOU EXTENSION 4 FILED |
| May 25, 2017 | EX4G | S | SOU EXTENSION 4 GRANTED |
| Nov 8, 2016 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Nov 7, 2016 | EX3G | S | SOU EXTENSION 3 GRANTED |
| Oct 12, 2016 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Oct 12, 2016 | EXT3 | S | SOU EXTENSION 3 FILED |
| Jul 9, 2016 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Jul 8, 2016 | EX2G | S | SOU EXTENSION 2 GRANTED |
| Jul 5, 2016 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Jun 2, 2016 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Jun 2, 2016 | EXT2 | S | SOU EXTENSION 2 FILED |
| Oct 8, 2015 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Oct 6, 2015 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Oct 6, 2015 | EXT1 | S | SOU EXTENSION 1 FILED |
| Oct 6, 2015 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Jun 2, 2015 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Apr 7, 2015 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Apr 7, 2015 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Mar 18, 2015 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Mar 3, 2015 | ALIE | A | ASSIGNED TO LIE |
| Mar 3, 2015 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Feb 13, 2015 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Feb 12, 2015 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Feb 12, 2015 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Feb 12, 2015 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Sep 2, 2014 | CNFR | R | FINAL REFUSAL WRITTEN |
| Sep 2, 2014 | GNFR | O | FINAL REFUSAL E-MAILED |
| Sep 2, 2014 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Aug 29, 2014 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Aug 28, 2014 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Aug 28, 2014 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Mar 5, 2014 | CPRA | R | PRIORITY ACTION WRITTEN |
| Mar 5, 2014 | GPRA | F | PRIORITY ACTION E-MAILED |
| Mar 5, 2014 | GPRN | O | NOTIFICATION OF PRIORITY ACTION E-MAILED |
| Mar 2, 2014 | DOCK | D | ASSIGNED TO EXAMINER |
| Jan 2, 2014 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Jan 2, 2014 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Jan 2, 2014 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Jan 2, 2014 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Jan 1, 2014 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Nov 27, 2013 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Nov 18, 2013 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological, hematologic and viral diseases and disorders; pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications, namely, antifungal preparations, dermatological preparations, smoking cessation preparations and tissue repair preparations
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005